Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Water Research|May 31, 2025
Silicon supplementation via carriers to enhance diatom competition with cyanobacterial blooms and remediate eutrophic watersRui Zhou, Bang Xiao, Li Zhao, et al.ESC Heart Failure|October 7, 2025
Assessing cardiovascular benefits of intensive blood pressure lowering in high-risk undiagnosed HFpEF patientsXinru Liu, Zhiyan Wang, Chang Hua, et al.Cytokine|September 5, 2020
Interleukin 3-induced GITR promotes the activation of human basophilsLi Hong, Yangyang Tang, Shuai Pan, et al.Journal of Hypertension|May 1, 2024
Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial studyZhiyan Wang, Wenjie Li, Chao Jiang, et al.Hypertension (Dallas, Tex. : 1979)|January 2, 2024
Effect of Intensive Blood Pressure Control on Cardiovascular Outcomes in Cancer SurvivorsWenjie Li, Zhiyan Wang, Chao Jiang, et al.Theranostics|March 23, 2021
<i>Aurka</i> loss in CD19<sup>+</sup> B cells promotes megakaryocytopoiesis via IL-6/STAT3 signaling-mediated thrombopoietin productionXin Chen, Chennan Wang, Na Sun, et al.Open Heart|October 22, 2025
Changes in frailty based on minimally important difference and the impact of spironolactone on frailty in heart failure with preserved ejection fraction: insights from the TOPCAT trialYangyang Tang, Wenjie Li, Zhiyan Wang, et al.Frontiers in Immunology|October 3, 2022
Identification of novel B-1 transitional progenitors by B-1 lymphocyte fate-mapping transgenic mouse model <i>Bhlhe41</i> <sup>dTomato-Cre</sup>Hui Li, Yangyang Tang, Jinfeng Ren, et al.Heart (British Cardiac Society)|February 6, 2025
The Impact of frailty on the effectiveness of intensive blood pressure control for patients with type 2 diabetes: a secondary analysis of a randomised controlled trialLi Wenjie, Zhiyan Wang, Mingxiao Li, et al.American Heart Journal|January 30, 2025
Study protocol for the healthy family program on population blood pressure: A multicenter, parallel group, cluster randomized, controlled trial in rural ChinaYangyang Tang, Chao Jiang, Jiakun Guo, et al.Pageof 5